Keyphrases
Acute Respiratory Distress Syndrome
13%
Adjusted Odds Ratio
13%
Aging
17%
AIDS/HIV
26%
Alzheimer's Disease
75%
Antibiotics
19%
Antibody Response
11%
Antiretroviral Therapy
17%
Apoptosis
13%
Asthma
15%
Autosomal Dominant Alzheimer's Disease
11%
B Cells
13%
Cardiovascular Disease
15%
CD8+ T Cells
17%
Central Nervous System
16%
Cerebrospinal Fluid
26%
Chikungunya Virus (CHIKV)
11%
Clinical Outcomes
21%
Clinical Trials
24%
Clinically Significant
11%
Cognitive Impairment
13%
Comorbidity
20%
Confidence Interval
61%
COVID-19
100%
COVID-19 Pandemic
17%
Dendritic Cells
26%
Dengue Virus
14%
Depressive Symptoms
12%
Disease Severity
12%
Emergency Department
27%
Epidemiology
16%
Epitope
16%
Flavivirus
12%
Functional Connectivity
11%
Gene Expression
19%
Genome-wide Association Study
15%
Genotype
11%
Hazard Ratio
14%
Head-and-neck Cancer
15%
Heart Failure
26%
High Risk
19%
HIV Patients
12%
Hospitalization
18%
Human Immunodeficiency Virus Type 1 (HIV-1)
11%
Immune Response
19%
Infectious Diseases
13%
Inflammation
22%
Influenza
11%
Influenza Virus
15%
Innate Immune Response
14%
Intensive Care Unit
18%
Interferon-α (IFN-α)
17%
Late-life Depression
13%
Lung
30%
Lung Transplantation
41%
Lymphatic Filariasis
17%
Macrophages
26%
Major Depressive Disorder
12%
Mass Drug Administration
11%
Meta-analysis
17%
Missouri
15%
Monoclonal Antibody
26%
Monocytes
14%
Mouse Model
15%
Mycobacterium Tuberculosis (M. tb)
11%
Natural Killer Cells
14%
Neutralizing Antibodies
14%
Neutrophils
12%
Odds Ratio
27%
Older Adults
62%
Older Patients
11%
Parkinson's Disease
40%
Patients with Heart Failure
11%
Pediatric
19%
People Living with HIV (PLHIV)
19%
Placebo
16%
Quality of Life
13%
Randomized Clinical Trial
18%
Randomized Controlled Trial
24%
Risk Factors
37%
Sepsis
40%
St. Louis
18%
Staphylococcus Aureus
12%
Surgical Site Infection
12%
Systematic Meta-analysis
11%
T Cells
28%
Transcription Factor
17%
Transplantation
12%
Trauma Patients
11%
Tuberculosis
11%
Type 1 Diabetes Mellitus (T1DM)
11%
United States
43%
Vaccination
17%
Vesicular Stomatitis Virus
14%
Viral
14%
Viral Infection
15%
Virus
41%
West Nile Virus
30%
West Nile Virus Infection
18%
Zika Virus
14%
Medicine and Dentistry
Acute Respiratory Distress Syndrome
8%
Adverse Event
12%
Allograft
10%
Alzheimer's Disease
36%
Amyloid Protein
13%
Antibiotics
12%
Antiretroviral Therapy
10%
Apoplexy
11%
Asthma
10%
B Cell
7%
Biological Marker
23%
Bleeding
12%
Bloodstream Infection
11%
Body Mass Index
7%
Cancer
7%
Cardiovascular Disease
14%
Cardiovascular System
11%
Central Nervous System
7%
Cerebrospinal Fluid
13%
Clinical Trial
21%
Clinician
26%
Cohort Analysis
13%
Cohort Effect
16%
Combination Therapy
7%
Comorbidity
17%
Congestive Heart Failure
34%
COVID-19
63%
Cross Sectional Study
7%
Cytomegalovirus
7%
Diabetes
12%
Diabetes Mellitus
12%
Diseases
71%
Drug Administration
9%
Emergency Department
25%
Gene Expression
8%
Geriatrics
7%
Gut
8%
Hazard Ratio
14%
Head and Neck Cancer
13%
Health Care
8%
Health Care Cost
15%
Health Care Personnel
15%
Human Immunodeficiency Virus
43%
Human Immunodeficiency Virus Infection
7%
Immune Response
9%
Immunosuppressive Treatment
8%
In Vitro
8%
Infection
75%
Infectious Disease
11%
Intensive Care
11%
Intensive Care Unit
21%
Left Ventricular Assist Device
9%
Logistic Regression Analysis
12%
Lung
31%
Lung Transplantation
32%
Lymphatic Filariasis
13%
Macrophage
10%
Magnetic Resonance Imaging
9%
Malignant Neoplasm
17%
Medicine
10%
Mental Health
11%
Messenger RNA
9%
Meta-Analysis
12%
Neoplasm
7%
Neuropathy
8%
Observational Study
11%
Odds Ratio
28%
Oral
12%
Outpatient
10%
Parkinson's Disease
9%
Pathogen
15%
Patient Care
7%
Pediatrics
39%
Pediatrics Patient
7%
Placebo
14%
Platelet
9%
Positron Emission Tomography
8%
Prevalence
23%
Primary Outcome
14%
Programmed Cell Death
11%
Public Health
8%
Quality of Life
17%
Randomized Clinical Trials
13%
Randomized Controlled Trial
21%
Receptor
9%
Recurrent Disease
7%
Retrospective Cohort Study
8%
Rheumatology
7%
Sepsis
30%
Serositis
8%
Severe Acute Respiratory Syndrome Coronavirus 2
40%
Surgical Infection
12%
Systematic Review
18%
T Cell
11%
Tau
11%
Tertiary Care
10%
Thrombosis
7%
Venous Thromboembolism
8%
Virus
17%
Virus Infection
12%